New stuttering drug shows promise in early trial

NCT ID NCT05583955

First seen Feb 03, 2026 · Last updated May 11, 2026 · Updated 17 times

Summary

This study tested a drug called NOE-105 in 75 adult men who have stuttered since childhood. The goal was to see if it could improve speech fluency without the side effects of older treatments. Participants took the drug or a placebo for 10 weeks, and researchers measured changes in stuttering severity and daily functioning.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHILDHOOD-ONSET FLUENCY DISORDER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Noema Investigator site

    Bellflower, California, 90706, United States

  • Noema Investigator site

    Jacksonville, Florida, 32256, United States

  • Noema Investigator site

    Orlando, Florida, 32801, United States

  • Noema Investigator site

    Overland Park, Kansas, 66210, United States

  • Noema Investigator site

    Berlin, New Jersey, 08009, United States

  • Noema Investigator site

    Memphis, Tennessee, 38119, United States

  • Noema Investigator site

    Brookvale, New South Wales, 2100, Australia

  • Noema Investigator site

    Miranda, New South Wales, 2228, Australia

  • Noema Investigator site

    Sydney, New South Wales, 2109, Australia

Conditions

Explore the condition pages connected to this study.